Head covering effects on serm calcium during phototherapy

Phase 2

• Conditions: Jaundice.; Haemorrhagic and haematological disorders of fetus and newborn; p50 , p51

• Registration Number: IRCT2013102315134N1
• Lead Sponsor: Vice chancellor for reasearch , Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 72

Inclusion Criteria

The major including criteria were : Full term;
Weighed more than 2500 grams; Had normal serum calcium; Apart from icterus; indirect bilirubin between13 to 18 mg/dl in full term neonates - their physical status was completely normal.
The major excluding criteria were: Asphyxia; respiratory distress; sepsis; hemolytic anemia; infants of mothers with diabetic or thyroid disorders.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bilirubin. Timepoint: The bilirubin level of each newborn were tested on arrival, 48 hours after phototherapy, and 24 hours following phototherapy. Method of measurement: Blood sample.;Calcium. Timepoint: The calcium level of each newborn were tested on arrival, 48 hours after phototherapy, and 24 hours following phototherapy. Method of measurement: Blood sample.;Magnesium. Timepoint: The calcium level of each newborn were tested on arrival, 48 hours after phototherapy, and 24 hours following phototherapy. Method of measurement: Blood sample.